Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilization of Autologous Mesenchymal Cells in Posterolateral Spinal Fusion in Degenerative Spine Disease to Assess the Safety and the Efficacy

NCT03827096 is registered in ClinicalTrials.gov with Bioinova, s.r.o. as lead sponsor.

NCT NCT03827096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03827096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilization of Autologous Mesenchymal Cells in Posterolateral Spinal Fusion in Degenerative Spine Disease to Assess the Safety and the Efficacy
Lead sponsor
Bioinova, s.r.o.
Phase
Phase 1/2
Overall status
Terminated
Start date
August 27, 2013
Completion date
December 14, 2016
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease